Abstract
Infusion of bone marrow or cytokine mobilized stem cells can be associated with severe and potentially life-threatening toxicities. The etiology of the toxicities can be related to volume of infusion, dimethylsulfoxide (DMSO) or bacterial or viral infection of the infused cell products. Serious toxicities including hypotension and hypertension, cardiac arrhythmias, and respiratory failure require the prompt attention by a trained physician. Non-life-threatening toxicities are common and include fever, chills, nausea and vomiting. Fever may be caused by an infection or cytokines released from leukocytes in the hematopoietic cell product. Other possible adverse events can be attributed to the reagents used in the processing procedure. Monitoring and management of toxicities and the roles of nurses, technicians, and physicians are outlined below.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Reference
Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D, Perotti C, Preti P, Robustelli della Cuna G (1998) Clinical Âtoxicity of Âcryopreserved circulating Âprogenitor cells Âinfusion. Anticancer Res 18:4705–4708
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Kaufman, J.L. (2012). Toxicities of Mobilized Stem Cell Infusion. In: Kolonin, M., Simmons, P. (eds) Stem Cell Mobilization. Methods in Molecular Biology, vol 904. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-943-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-61779-943-3_10
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-942-6
Online ISBN: 978-1-61779-943-3
eBook Packages: Springer Protocols